Oxford Biomedica PLC/ GB00BDFBVT43 /
10/10/2024 17:24:36 | Chg. +1.75 | Volume | Bid17:30:00 | Ask17:30:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
386.00GBX | +0.46% | 2,926 Turnover(GBP): 11,276.7825 |
-Bid Size: - | -Ask Size: - | 308.02 mill.GBP | - | - |
Fundamentals
FY 2020 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 0.08 GBP | -64.98 |
EPS Diluted: | 0.08 GBP | - |
Revenues per Share: | 1.10 GBP | 24.44% |
Book Value per Share: | 1.41 GBP | 35.58% |
Cash Flow per Share: | 0.04 GBP | - |
Dividend per Share: | 0.00 GBP | - |
Total | in mill. | |
Revenues: | 87.70 GBP | 36.82% |
Net Income: | -6.20 GBP | -61.49% |
Operating Cash Flow: | 3.10 GBP | - |
Cash and Cash Equivalents: | 46.70 GBP | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 49.33 | 129.32 |
P/S Ratio: | 3.51 | 9.21 |
P/BV ratio: | 2.73 | 7.16 |
P/CF Ratio: | 99.36 | 260.47 |
PEG: | - | - |
Earnings Yield: | 2.03% | 0.77% |
Dividend Yield: | 0.00% | 0.00% |
Market Capitalization | ||
Market Capitalization: | 308.02 mill. GBP | 807.44 mill. GBP |
Free Float Market Cap.: | 154.62 mill. GBP | 405.34 mill. GBP |
Market Cap. / Employee: | 457,675.4843 GBP | 1.2 mill. GBP |
Shares Outstanding: | 79.95 mill. |
Profitability
Gross Profit Margin: | 52.57% |
EBIT Margin: | -6.50% |
Net Profit Margin: | -7.07% |
Return on Equity: | -5.50% |
Return on Assets: | -3.37% |
Financial Strength
Liquidity I / Cash Ratio: | 88.95% |
Liquidity II / Quick Ratio: | 191.62% |
Liquidity III / Current Ratio: | 205.52% |
Debt / Equity Ratio: | 63.18% |
Dynam. Debt / Equity Ratio: | 2,296.77% |
Efficiency
Employees: | 673 |
Personal Expenses / Employee: | - GBP |
Revenues / Employee: | 130,312.04 GBP |
Net Income / Employee: | -9,212.48 GBP |
Total Assets / Employee: | 273,254.09 GBP |
* Fiscal Year End: | 31/12/2020 |
Accounting Standard: | IFRS |
Currency: | GBP |